IPO Trending
APLSME / BSEListed

Asston Pharmaceuticals Limited

Asston Pharmaceuticals Limited, established in 2019, is a pharmaceutical company focused on exporting healthcare products worldwide. It offers a wide range of products, including tablets, capsules, sachets, and syrups. These cover various therapeutic areas such as pain relief, antibiotics, antifungals, vitamins, and more. The company manufactures medicines for its own sales as well as on a contract basis, mainly working directly with different marketers. It holds certifications from both Central and State FDA, along with NQA accreditation, and follows Quality Management System standards to maintain product quality. As of July 3, 2025, the company employs 46 permanent staff and 6 contractual workers across different departments.

₹115 - ₹123186.59x sub
Listed Price119.00
Listing Gain-3.25%
Subscription186.59x total demandUpdated 01 Jun 2026, 05:49 AM
QIB85.76x
🔥 Blockbuster Sizzling Demand!Offered: 4,25,000 sh
Nib353.15x
🔥 Blockbuster Sizzling Demand!Offered: 3,22,000 sh
Hnis(10l +)423.95x
🔥 Blockbuster Sizzling Demand!Offered: 2,15,000 sh
Hnis (2-10l)208.93x
🔥 Blockbuster Sizzling Demand!Offered: 1,08,000 sh
Retail172.14x
🔥 Blockbuster Sizzling Demand!Offered: 7,46,000 sh
CategoryOfferedAppliedTimes
QIB4,25,0003,64,49,00085.76x
Nib3,22,00011,37,13,000353.15x
Hnis(10l +)2,15,0009,11,49,000423.95x
Hnis (2-10l)1,08,0002,25,64,000208.93x
Retail7,46,00012,84,16,000172.14x
Segment Subscription Demand
Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB05.23Open
Retail1.169.180.13x
Hnis 2+0.341.330.26x
Hnis 10+02.64Open
Application-wise Breakup
CategoryReservedAppliedTimes Sub.
Retail37364,208172.14x
Hnis(10l +)728,616119.67x
Hnis (2-10l)366,457179.36x
Asston Pharmaceuticals Limited IPO Subscription | GMP, Allotment & Financials | IPO Trending